Navigation Links
From the (very) small to the 'big picture'
Date:6/12/2008

London, ON One looks at the 'small science' of nanomaterials, the other looks at big picture issues with the Canadian health care system. Today at The University of Western Ontario, both Franois Lagugn-Labarthet and Amardeep Thind were awarded Canada Research Chairs one of the country's most prestigious research awards.

The Chairs program has been designed to encourage and promote top research and innovation in universities. Tier One Chairs receive $200,000 annually for seven years to fund their research and are awarded to outstanding researchers who have developed reputations as world leaders in their fields. Tier Two Chairholders receive $100,000 annually for five years and are recognized as exceptional and emerging researchers with the potential to lead their respective fields.

Nanomaterials are becoming increasingly important as we strive to make smaller, faster and smarter components and devices. On a scale of one-billionth of a metre in size, however, they can be difficult to see and to analyse. As the new Tier Two Canada Research Chair in Nanomaterials and Photonics, Lagugn-Labarthet and his group are developing and combining new optical techniques that allow scientists to study nanomaterials' properties with high resolution capabilities. This is particularly important for the further development of nanostructures in biological and materials research.

"Traditional imaging techniques can intrinsically be limited in providing molecule-specific information, or in probing physical and optical properties," says Lagugn-Labarthet, who is an assistant professor in the chemistry department. Instead, he characterizes nano-objects using lasers and advanced optical microscopy techniques that provide information about the properties and functions of nanomaterials in correlation with their size, structure and composition. Rapid developments in the field of nanoscience have led to a range of promising applications, including bit-elements in supercomputers, molecular receptors capable of trapping and detecting air or water pollutants, sensors for disease diagnosis and drug delivery carriers.

Thind, an associate professor in the department of epidemiology and biostatistics at the Schulich School of Medicine & Dentistry, is developing a better understanding of our health care system and providing direction for reducing wait times and resource shortages. "A well-functioning health care system requires minimal barriers to entry," he says. "Access remains an issue even in Canada's universal health care system."

Awarded the Tier Two Canada Research Chair in Health Services Research, Thind will help policy makers improve access for Canadians by looking at what happens before and after patients gain access to the health care system, focusing on wait times that exist between seeing a family physician and a specialist. He will also study determinants of access in countries that contribute a majority of new immigrants to Canada, which is particularly relevant given Statistics Canada predictions that population increases in this country will be driven entirely by immigration by the year 2030. Thind's program will also develop models of access and outcomes for low income women receiving treatment for breast cancer in the United States.

Three Chairholders at Western also had their CRCs renewed for another term:

  • Tier One CRC in Medical Imaging, Aaron Fenster;
  • Tier One CRC in Visual Neuroscience, Melvyn Goodale;
  • Tier One CRC in Human Genetics and Phenomics, Robert Hegele.


'/>"/>

Contact: Douglas Keddy
dkeddy@uwo.ca
519-661-2111
University of Western Ontario
Source:Eurekalert

Related medicine news :

1. Democratic National Committee McCain Myth Buster: John McCain and Americas Small Businesses
2. VIDEO from Medialink and Abiomed: Worlds Smallest Heart Pump Receives 510(K) Clearance from FDA
3. Being Born Small, Early Raises Autism Risk
4. Governor Rendell Says PA ABC Will Help Low-Wage Small Businesses Pay for Employee Health Coverage
5. Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
6. 1 small step for a lab science, 1 green leap for mankind
7. PA ABC Will Benefit Commonwealths Small Businesses, DCED Secretary Says
8. How does sodium phosphate combined with bisacodyl affect small intestine?
9. Smallpox Drug May Protect Against Common Cold
10. ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
11. Health Plan Execs Receive Smaller Bonuses as Companies Push Performance-Based Pay, HPW Reports; Hanway Tops Others in Total Compensation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Gym Source, ... of a new showroom at South Dixie Hwy in Miami, FL. , “We are ... Gym Source. “The new innovative in-store concept is designed to give clients a seamless ...
(Date:1/17/2017)... Los Angeles, CA (PRWEB) , ... January 17, ... ... conflicted and concerned by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting ... tragedies and magical moments that help everyone endure and pass through tough times, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Kevin Harrington (one of the original Sharks ... DRTV campaigns regarding the topic of Beauty and Personal Care. , ... What better way to commit to these changes than beginning with personal care and ...
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve TMS West, with multiple ... new office in San Clemente, California this month. Achieve TMS West is the ... treating individuals struggling with major depression. Depression impacts over 15 million adults in ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is pleased to ... on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more ... addition to our provider network, and the addition will benefit our members in ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global fluoropolymer market in the healthcare industry to grow ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/17/2017)... Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, today announced ... pharmaceutical development at Tocagen, will present at Phacilitate Cell & ... Miami . Details of the ... ... - what to do when and why Date and Time: Wednesday, ...
(Date:1/17/2017)... 2017 Research and Markets has announced the ... Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug ... 2021" report to their offering. ... The global active pharmaceutical ingredients market is ... Billion in 2016, growing at a CAGR of 6.3% from 2016 ...
Breaking Medicine Technology: